paywalled: Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted? Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, December 23, 2016

paywalled: Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?



Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?
 

Highlights

The guidelines endorse neoadjuvant chemotherapy for potentially resectable disease.
Women with no residual disease after primary surgery have the best survival rates.
All women with potentially resectable disease should strive for this outcome.

0 comments :

Post a Comment

Your comments?